Back to (new) normality-A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2.

Published on Nov 4, 2020in Medical Oncology2.834
· DOI :10.1007/S12032-020-01434-1
Barbara Alicja Jereczek-Fossa36
Estimated H-index: 36
(IEO: European Institute of Oncology),
Giulia Marvaso14
Estimated H-index: 14
(IEO: European Institute of Oncology)
+ 34 AuthorsMauro Palazzi1
Estimated H-index: 1
Sources
Abstract
Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of the pandemic. The present survey study, endorsed by CODRAL and AIRO-L, aimed to assess how radiotherapy (RT) departments in Lombardy have dealt with the recovery. A questionnaire dealing with the management of pandemic was developed online and sent to all CODRAL Directors on the 10th of June 2020. Answers were collected in full anonymity one week after. All the 33 contacted RT facilities (100%) responded to the survey. Despite the scale of the pandemic, during P1 14 (42.4%) centres managed to safely continue the activity (≤ 10% reduction). During P2, 10 (30.3%) centres fully recovered and 14 (42.4%) reported an increase. Nonetheless, 6 (18.2%) declared no changes and, interestingly, 3 (9.1%) reduced activities. Overall, 21 centres (63.6%) reported suspected or positive cases within healthcare workforce since the beginning of the pandemic. Staff units were quarantined in 19 (57.6%) and 6 (18.2%) centres throughout P1 and P2, respectively. In the two phases, about two thirds centres registered positive or suspected cases amongst patients. The study revealed a particular attention to anti-contagion measures and a return to normal or even higher clinical workload in most RT centres in Lombardy, necessary to carry out current and previously deferred treatments.
References30
Newest
#1Salvina BarraH-Index: 17
#2Alessia Guarnieri (UNITO: University of Turin)H-Index: 2
Last. Renzo Corvò (UniGe: University of Genoa)H-Index: 28
view all 9 authors...
INTRODUCTION: To evaluate stereotactic body radiotherapy (SBRT) in low-risk Prostate Cancer patients as preferred treatment option in emergency health conditions. MATERIALS AND METHODS: From April 2013 to September 2015, 28 patients with low-risk prostate cancer were prospectively enrolled. The SBRT prescribed dose was 36.25 Gy in 5 fractions, twice a week. Primary endpoints were acute and late toxicity. Secondary endpoints were biochemical recurrence free survival (bRFS) and overall survival. R...
6 CitationsSource
#1Dekang Zhang (University of Electronic Science and Technology of China)H-Index: 1
#2Tao Li (University of Electronic Science and Technology of China)H-Index: 104
Last. Jinyi Lang (University of Electronic Science and Technology of China)H-Index: 14
view all 11 authors...
Abstract After the outbreak of COVID-19, medical institutions in China and even around the world are facing unprecedented challenges. In order to minimize the adverse impact of this unexpected epidemic on patients who need radiotherapy, the expert group of our radiotherapy center immediately formulated comprehensive emergency plans and prevention and control measures, partitioned the work area, launched online staff training, and optimized the radiotherapy process after the outbreak, which provi...
2 CitationsSource
#1Barbara Alicja Jereczek-Fossa (University of Milan)H-Index: 36
Last. Vittorio DonatoH-Index: 11
view all 25 authors...
Abstract Italy experienced one of the world’s deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.
24 CitationsSource
#1Corinne Faivre-Finn (University of Manchester)H-Index: 50
#2John D. Fenwick (University of Liverpool)H-Index: 26
Last. E. ToyH-Index: 1
view all 14 authors...
Abstract Patients treated with curative-intent lung radiotherapy are in the group at highest risk of severe complications and death from COVID-19. There is therefore an urgent need to reduce the risks associated with multiple hospital visits and their anti-cancer treatment. One recommendation is to consider alternative dose-fractionation schedules or radiotherapy techniques. This would also increase radiotherapy service capacity for operable patients with stage I-III lung cancer, who might be un...
21 CitationsSource
#1Can ObekH-Index: 15
#2Tunkut DogancaH-Index: 6
Last. Ali Riza KuralH-Index: 20
view all 4 authors...
Prostate cancer patients’ management demands prioritization, adjustments, and a tailored approach during the unprecedented SARS-CoV-2 pandemic. Benefit of care from treatment must be carefully weighed against the potential of infection and morbidity from COVID-19. Furthermore, urologists need to be cognizant of their obligation for wise consumption of restricted healthcare resources and protection of the safety of their coworkers. Nonurgent in-person clinic visits should be postponed or conducte...
13 CitationsSource
#1David J Thomson (University of Manchester)H-Index: 11
#2David A. Palma (UWO: University of Western Ontario)H-Index: 55
Last. Sue S. Yom (UCSF: University of California, San Francisco)H-Index: 40
view all 32 authors...
Introduction Due to the unprecedented disruption of health care services by the COVID-19 pandemic, the American Society of Radiation Oncology (ASTRO) and the European Society for Radiotherapy and Oncology (ESTRO) identified an urgent need to issue practice recommendations for radiation oncologists treating head and neck cancer (HNC), in a time of heightened risk for patients and staff, and of limited resources. Methods A panel of international experts from ASTRO, ESTRO and select Asia-Pacific co...
105 CitationsSource
#1Matthias Guckenberger (UZH: University of Zurich)H-Index: 70
#1Esther G.C. Troost (HZDR: Helmholtz-Zentrum Dresden-Rossendorf)H-Index: 36
Last. David A. Palma (UWO: University of Western Ontario)H-Index: 55
view all 32 authors...
Background The COVID-19 pandemic has caused radiotherapy resource pressures and led to increased risks for lung cancer patients and healthcare staff. An international group of experts in lung cancer radiotherapy established this practice recommendation pertaining to whether and how to adapt radiotherapy for lung cancer in the COVID-19 pandemic. Methods For this ESTRO & ASTRO endorsed project, 32 experts in lung cancer radiotherapy contributed to the consensus process using a modified Delphi proc...
107 CitationsSource
#1Kathy Han (Princess Margaret Cancer Centre)H-Index: 14
#2Lucas C. Mendez (London Health Sciences Centre)H-Index: 10
Last. Eric Leung (U of T: University of Toronto)H-Index: 10
view all 12 authors...
2 CitationsSource
#1Zahra Siavashpour (Shahid Beheshti University of Medical Sciences and Health Services)H-Index: 6
#2Farzad Taghizadeh-Hesary (Shahid Beheshti University of Medical Sciences and Health Services)H-Index: 8
Last. Afshin Rakhsha (Shahid Beheshti University of Medical Sciences and Health Services)H-Index: 5
view all 3 authors...
PURPOSE: Today, the rapid outbreak of COVID-19 is the leading health issue. Patients with cancer are at high risk for the development of morbidities of COVID-19. Hence, oncology centers need to provide organ-based recommendations for optimal management of cancer in the COVID-19 era. METHODS: In this article, we have provided the recommendations on management of locally advanced rectal cancer during the COVID-19 pandemic based on our experience in Shohada-e Tajrish Hospital, Iran. RESULTS: We rec...
6 CitationsSource
#1Weiping Wang (Peking Union Medical College Hospital)H-Index: 8
#2Ke Hu (Peking Union Medical College Hospital)H-Index: 11
Last. Fuquan Zhang (Peking Union Medical College Hospital)H-Index: 10
view all 4 authors...
The daily new confirmed Coronavirus disease 2019 (COVID-19) cases have decreased in some European and Asian countries. Many countries and areas have started to ease public restrictions. Here, we share our experiences and recommendations on how to conduct radiotherapy after public restrictions have eased or upon reopening. Firstly, COVID-19 nucleic acid test screening should be performed for all new admitted patients in areas with enough test capability. Secondly, radiotherapy can be conducted re...
1 CitationsSource
Cited By2
Newest
#1Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 36
#2Mauro PalazziH-Index: 11
Last. Carlo Pietro SoattiH-Index: 4
view all 37 authors...
Lombardy has represented the Italian and European epicenter of the coronavirus disease 2019 (COVID-19) pandemic. Although most clinical efforts within hospitals were diverted towards the care of virally infected patients, therapies for patients with cancer, including radiotherapy (RT), have continued. During both the first and second pandemic waves, several national and regional organizations provided Italian and Lombardian RT departments with detailed guidelines aimed at ensuring safe treatment...
Source
#1Giulia Corrao (IEO: European Institute of Oncology)H-Index: 6
#2Luca Bergamaschi (IEO: European Institute of Oncology)H-Index: 9
Last. Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 36
view all 12 authors...
Aim:Since 20 February 2020, Lombardy has been one of the most affected areas worldwide by the coronavirus disease 2019 (COVID-19) pandemic. The aim of this study is to evaluate work and psychologic...
Source